Keywords: Parkinson's Disease, Parkinson's Disease, Neuromelanin MRI
Motivation: The potential of neuromelanin-MRI in tracking disease progression is underexplored.
Goal(s): We investigated the detectability of changes of contrast in substructures of the substantia nigra over 6 months.
Approach: We compared changes of contrast between healthy controls and subjects with early PD.
Results: Depigmentation progresses over 6 months in early PD, but not in healthy controls, advancing the use of neuromelanin-MRI as a potential marker of PD.
Impact: Our study addresses the knowledge gap of neuromelanin-MRI as a potential progression marker of early PD, which will be particularly helpful in the context of future disease-modifying trials.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords